CASE REPORT
Vitamin D toxicity with acute kidney injury in siblings – a case report and literature review
 
More details
Hide details
1
Students’ Scientific Group, Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland
 
2
Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland
 
 
Submission date: 2025-05-04
 
 
Final revision date: 2025-07-07
 
 
Acceptance date: 2025-07-28
 
 
Publication date: 2025-12-15
 
 
Corresponding author
Tomasz Szawłoga
Tomasz Szawłoga, Students’ Scientific Group, Department of Pediatric Nephrology, Medical University of Lublin, Lublin, Poland
 
 
Pediatr Pol 2025;61(4):387-393
 
KEYWORDS
TOPICS
ABSTRACT
Vitamin D toxicity is a significant and increasingly diagnosed clinical issue. Despite clearly defined guidelinesw for the prevention and treatment of its deficiency, a growing trend of unsupervised high-dose supplementation is observed. We present two brothers who took 10,000 IU of cholecalciferol daily for over a month. One developed nonspecific symptoms of severe hypercalcemia (4.07 mmol/l) and acute kidney injury (eGFR 63), with serum 25(OH)D of 610 ng/ml. The other patient remained nearly asymptomatic despite a markedly elevated 25(OH)D level (501 ng/ml) and hypercalcemia (3.13 mmol/l). The applied treatment – glucocorticoids, forced diuresis, and electrolyte supplementation – caused normalization of calcemia and renal function. The presented case illustrates the broad spectrum of clinical manifestations associated with vitamin D toxicity and underscores the need to raise public awareness of the dangers linked to its excessive supplementation. It also emphasizes the importance of medical supervision when using vitamin D, particularly in children.
REFERENCES (30)
1.
Delrue C, Speeckaert MM. Vitamin D and vitamin D-binding protein in health and disease. Int J Mol Sci 2023; 24: 4642.
 
2.
Bikle DD. Vitamin D: production, metabolism and mechanisms of action. In: Feingold KR, Anawalt B, Blackman MR (eds). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/b... (accessed from: 23.10.2024).
 
3.
Zhang X, Liu Z, Xia L, Gao J, Xu F, Chen H, et al. Clinical features of vitamin D deficiency in children: a retrospective analysis. J Steroid Biochem Mol Biol 2020; 196: 105491.
 
4.
Gil Á, Plaza-Diaz J, Mesa MD. Vitamin D: classic and novel actions. Ann Nutr Metab 2018; 72: 87-95.
 
5.
Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska- Ziółkiewicz D, Sieroszewski P, et al. Guidelines for preventing and treating vitamin D deficiency: a 2023 update in Poland. Nutrients 2023; 15: 695.
 
6.
Płudowski P, Ducki C, Konstantynowicz J, Maciej Jaworski. Vitamin D status in Poland. Pol Arch Med Wewn 2016; 126: 530-539.
 
7.
Wan M, Patel J, Rait G, Shroff R. Hypervitaminosis D and nephrocalcinosis: too much of a good thing? Pediatr Nephrol 2022; 37: 2225-2229.
 
8.
Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer DC, Bishop N, et al. Clinical practice recommendations for native vitamin D thera­py in children with chronic kidney disease stages 2–5 and on dialysis. Nephrol Dial Transplant 2017; 32: 1098-1113.
 
9.
Braegger C, Campoy C, Colomb V, Decsi T, Domellof M, Few- trell M, et al. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 2013; 56: 692-701.
 
10.
Graidis S, Papavramidis TS, Papaioannou M. Vitamin D and acute kidney injury: a two-way causality relation and a predictive, prognostic, and therapeutic role of vitamin D. Front Nutr 2021; 7: 630951.
 
11.
Vogiatzi MG, Jacobson-Dickman E, DeBoer MD. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab 2014; 99: 1132-1141.
 
12.
Brustad N, Yousef S, Stokholm J, Bønnelykke K, Bisgaard H, Chawes BL. Safety of high-dose vitamin D supplementation among children aged 0 to 6 years: a systematic review and meta-analysis. JAMA Netw Open 2022; 5: e227410.
 
13.
Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkie- wicz J, Płudowski P, Jones G. Vitamin D toxicity-a clinical perspective. Front Endocrinol (Lausanne) 2018; 9: 550.
 
14.
Tobias DK, Luttmann-Gibson H, Mora S, Danik J, Bubes V, Copeland T, et al. Association of body weight with response to vitamin D supplementation and metabolism. JAMA Netw Open 2023; 6: e2250681.
 
15.
Cappellani D, Brancatella A, Morganti R, Borsari S, Baldinotti F, Caligo MA, et al. Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review. Eur J Endocrinol 2021; 186: 137-149.
 
16.
Silvestre C, Aragües JM, Bugalho MJ, Jones G, Kaufmann M. Idiopathic infantile hypercalcemia presenting in childhood but diagnosed in adulthood. AACE Clin Case Rep 2018; 4: 256-262.
 
17.
Deshpandey RP, Kumar HSA, Mathew S. Dyselectrolytemias and acidbase disorder in acute kidney injury. Clin Queries Nephrol 2012; 1: 70-75.
 
18.
Markowitz GS, Perazella MA. Acute phosphate nephropathy. Kidney Int 2009; 76: 1027-1034.
 
19.
De Francesco Daher E, Mesquita Martiniano LV, Lopes Lima LL, Filho NCVL, de Oliveira Souza LE, Palácio Duarte Fernandes PH, et al. Acute kidney injury due to excessive and prolonged intramuscular injection of veterinary supplements containing vitamins A, D and E: a series of 16 cases. Nefrología 2017; 37: 61-67.
 
20.
Lin TH, Lu HJ, Lin CH, Lee MD, Chang BPH, Lin CC, et al. Nephrocalcinosis in children who received high-dose vitamin D. Pediatr Nephrol 2022; 37: 2471-2478.
 
21.
Martinaityte I, Kamycheva E, Didriksen A, Jakobsen J, Jorde R. Vitamin D stored in fat tissue during a 5-year intervention affects serum 25-hydroxyvitamin d levels the following year. J Clin Endocrinol Metabol 2017; 102: 3731-3738.
 
22.
Chorin E, Rosso R, Viskin S. Electrocardiographic manifestations of calcium abnormalities. Ann Noninvasive Electrocardiol 2016; 21: 7-9.
 
23.
Ejaz AA, Mu W, Kang DH, Roncal C, Sautin YY, Henderson G, et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2007; 2: 16-21.
 
24.
Isnuwardana R, Bijukchhe S, Thadanipon K, Ingsathit A, Thakkinstian A. Association between vitamin D and uric acid in adults: a systematic review and meta-analysis. Horm Metab Res 2020; 52: 732-741.
 
25.
Zhang YY, Qiu HB, Tian JW. Association between vitamin D and hyperuricemia among adults in the United States. Front Nutr 2020; 7: 592777.
 
26.
Simm PJ, Biggin A, Zacharin MR, Rodda CP, Tham E, Siafarikas A, et al. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health 2018; 54: 223-233.
 
27.
Sayers J, Hynes AM, Srivastava S, Dowen F, Quinton R, Datta HK, et al. Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole. Clin Kidney J 2015; 8: 453-455.
 
28.
Kilci F, Jones JH, Çizmecioğlu-Jones FM. Successful management of severe hypercalcemia with zoledronic acid: a report of two pediatric cases. J Clin Res Pediatr Endocrinol 2024; 16: 224-228.
 
29.
Heister DJ, Bohnert BN, Heyne N, Birkenfeld AL, Artunc F. Two cases of severe vitamin D3 intoxication treated with therapeutic plasma exchange and high cut-off hemodialysis. J Nephrol 2023; 36: 1461-1467.
 
30.
Hasan HR, Al-Fatlawi ACY, Al-Obaidy QM. Evaluation of the levels of kidney injury molecule-1 and cystatin C as early biomarkers for prediction of acute kidney injury complications in paediatric male patients – a case-control study. Pediatr Pol 2025; 100: 38-51.
 
Journals System - logo
Scroll to top